Metshine-GP 2 Tablet ER
Marketer
Alexa Organics Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Metshine-GP 2 Tablet ER
GlycoBalance XR is a dual-action formulation designed to manage blood glucose. This medication complements diet and exercise to optimize blood sugar control in adult patients with type 2 diabetes. It enhances insulin effectiveness, consequently reducing blood sugar. GlycoBalance XR should be administered precisely as prescribed by your physician, with food to minimize digestive discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; in such cases, skip the missed dose and resume the regular regimen. Never double the dose. Excessive intake may result in hypoglycemia (low blood sugar). Concomitant use with other diabetes medications, alcohol, or skipped meals may increase the risk of hypoglycemia. Regular blood glucose monitoring is essential. Commonly reported side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Baseline kidney function tests will be conducted before treatment initiation. Limit alcohol consumption, as it may heighten the risk of adverse reactions.
Primary Ingredients of Metshine-GP 2 Tablet ER
No text provided to rephrase.
Uses of Metshine-GP 2 Tablet ER
Managing type 2 diabetes
Major Benefits of Metshine-GP 2 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Metshine-GP 2 Tablet ER with a meal.
Common Side effects of Metshine-GP 2 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Metshine-GP 2 Tablet ER:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Metshine-GP 2 Extended-Release Tablet should be administered with a meal.
How Metshine-GP 2 Tablet ER works:
Metshine-GP 2 ER tablets contain a triple combination of glimepiride, metformin, and pioglitazone—antidiabetic agents with distinct modes of action. This formulation enhances blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Metshine-GP 2 Tablet ER ingestion poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Metshine-GP 2 Tablet ER during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Metshine-GP 2 tablets pose a likely risk during lactation. Available human data indicate potential transfer to breast milk, potentially harming the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when prescribing Metshine-GP 2 ER tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician. Metshine-GP 2 ER tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal parameters is recommended during treatment.
LiverCAUTION
Exercise caution when prescribing Metshine-GP 2 Tablet ER to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician before administering. Metshine-GP 2 Tablet ER is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Metshine-GP 2 Tablet ER :
Should you forget a dose of Metshine-GP 2 Tablet ER, take it immediately if you remember. However, near the time for your next scheduled dose, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metshine-GP 2 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently